BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Board Director Changes SEC Filings β€” February 18, 2026

USA Board Room Changes

34 high priority34 total filings analysed

Executive Summary

A remarkable surge of 34 US companies filed 8-Ks on February 19, 2026, exclusively under Item 5.02 for boardroom changes including potential CEO/CFO/director departures, appointments, or compensatory arrangements, signaling unprecedented one-day governance activity across sectors. All filings exhibit uniform neutral sentiment with no disclosed specifics on positions affected, individuals, reasons, timing, or quantitative impacts, limiting direct assessment but highlighting pervasive disclosure gaps that elevate systemic governance uncertainty. Notable clustering in financials (5 companies: CVB Financial, Old National Bancorp, BOK Financial, National Bank Holdings, Hanover Bancorp) suggests sector-specific pressures, while consumer (YETI, Texas Roadhouse, Sprouts, WD-40) and tech (Paycom, Synopsys, GoPro) also feature prominently. No enriched period-over-period trends, insider trading, forward-looking guidance, capital allocation details, financial ratios, or operational metrics are provided across any filing, precluding quantitative portfolio trends but underscoring a qualitative red flag on transparency amid accompanying Reg FD (Item 7.01) and results (Item 2.02) disclosures in 12+ cases. This volume implies potential coordinated leadership shifts or external catalysts (e.g., regulatory, M&A prep), warranting immediate monitoring for follow-on filings to discern bullish succession planning vs. bearish instability. Average materiality 4.4/10 with 10+ medium-risk flags on undisclosed details points to portfolio-level watch rather than immediate trades.

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 17, 2026.

Investment Signals(12)

  • β–²

    Officer change + bylaws amendment (Item 5.03) + Reg FD disclosure, highest materiality 6/10 indicating structured governance evolution amid software sector stability

  • β–²

    Officer change with Reg FD and exhibits, medium risk but materiality 6/10 suggests planned compensatory arrangements enhancing consumer goods leadership

  • Key tech officer shift (materiality 6/10) potentially bolstering optoelectronics amid sector growth, no negative metrics disclosed

  • Officer change + results disclosure (Item 2.02), large 8MB filing hints at detailed succession in REITs trading at discount

  • β–²

    Officer change tied to results (Item 2.02), potential positive planned succession in restaurants per summary opportunity note

  • β–²

    Officer change + Reg FD in semiconductor design leader, neutral but positions for strategic hires in high-growth EDA market

  • Officer appointment potential in healthy foods retailer, medium materiality supports leadership refresh for expansion

  • YETI Holdings↓(NEUTRAL-BULLISH)
    β–²

    Officer change with Reg FD, materiality 5/10 in premium consumer durables signals alignment with growth trajectory

  • Balchem Corp↓(NEUTRAL-BULLISH)
    β–²

    Officer event in specialty chemicals, medium risk but no downside metrics flags stability in niche margins

  • β–²

    Officer change + other events, homebuilder positioning for housing cycle upturn via board refresh

  • ManpowerGroup↓(NEUTRAL-BULLISH)
    β–²

    Officer disclosure in staffing firm amid labor market shifts, low materiality but timely for talent realignment

  • Expeditors Intl(BULLISH)
    β–²

    Logistics officer change, low risk supports operational continuity in global trade recovery

Risk Flags(10)

  • Financial Sector Cluster (CVB Financial, Old National, BOK, National Bank, Hanover)[HIGH RISK]
    β–Ό

    5 banks with simultaneous Item 5.02 filings, undisclosed details signal potential regulatory-driven churn or instability

  • β–Ό

    Bylaws amendment (Item 5.03) + officer change without specifics, medium risk of unknown governance shifts in software

  • β–Ό

    Officer change + bylaws change (Item 5.03), lack of details on amendments raises control structure concerns

  • β–Ό

    Multi-item filing (5.02/5.03/5.07/7.01) with no voting outcomes or change details disclosed, potential board control issues

  • YETI Holdings↓[MEDIUM RISK]
    β–Ό

    No officer position/reason details, medium risk in consumer amid potential leadership vacuum

  • β–Ό

    Item 2.02 results undisclosed alongside officer change, uncertainty on financial health impact

  • β–Ό

    Unknown biotech officer shift, medium risk of instability in development-stage firm

  • Tech officer change details absent, medium risk signaling governance concerns in volatile semis

  • β–Ό

    Critical missing info on officer (name/title/reason), limits assessment in competitive grocery

  • β–Ό

    Pharma officer change undisclosed, medium risk amid pipeline dependencies

Opportunities(10)

  • Financials Cluster (CVB, Old National, BOK etc.)(OPPORTUNITY)
    β—†

    5-bank churn on one day offers short-term volatility play if follow-ons reveal appointments over resignations

  • β—†

    High materiality 6/10 + Reg FD suggests forward guidance tie-in, alpha from parsing upcoming earnings for leadership boost

  • WD-40 Co↓(OPPORTUNITY)
    β—†

    Consumer staple with 6/10 materiality, opportunity in stable dividends if change enhances margins (no compression noted)

  • β—†

    Planned succession potential per summary, pair with Item 2.02 results for restaurant sector outperformance

  • β—†

    REIT officer refresh + results disclosure (8MB file), undervalued if strengthens asset management post-change

  • Synopsys↓(OPPORTUNITY)
    β—†

    EDA leader's officer change positions for AI/chip design catalysts, watch for insider follow-on buys

  • β—†

    Grocery leadership upgrade opportunity in organic growth segment vs. peers

  • β—†

    Homebuilder board event amid housing shortage, potential for order backlog acceleration post-change

  • Balchem Corp↓(OPPORTUNITY)
    β—†

    Niche chem firm with medium materiality, alpha if appointment brings M&A expertise

  • GoPro↓(OPPORTUNITY)
    β—†

    Action cam maker's change could signal turnaround pivot, low risk entry for consumer tech rebound

Sector Themes(6)

  • Banking Governance Churn(THEME)
    β—†

    5/34 filings (15%) from financials (CVB, Old National, BOK, National Bank, Hanover) on single day, undisclosed details imply regulatory or consolidation pressures; monitor NIM trends in follow-ons

  • Consumer Discretionary Refresh(THEME)
    β—†

    20%+ involvement (YETI, Texas Roadhouse, Sprouts, Lucky Strike, WD-40), neutral sentiment but medium materiality average flags leadership alignment for post-inflation spending recovery

  • Tech/Software Leadership Shifts(THEME)
    β—†

    Paycom, Synopsys, Applied Opto, GoPro show 12% cluster, Reg FD ties suggest strategic hires for AI/cloud growth without disclosed margin hits

  • Transparency Deficit Across All(THEME)
    β—†

    100% of 34 filings lack position/reason details, elevating medium-risk flags in 29%; pattern raises portfolio governance risk premium

  • REIT/Real Estate Uncertainty(THEME)
    β—†

    Park Hotels, NNN REIT with officer changes + disclosures, potential for dividend stability if appointments vs. departures

  • Multi-Item Filings Pattern(THEME)
    β—†

    9/34 include 5.03 amendments or 2.02 results (e.g., Matthews, Paycom), undisclosed content hints at broader catalysts beyond board changes

Watch List(8)

Filing Analyses(34)
BETA Technologies, Inc.8-Kneutralmateriality 3/10

19-02-2026

BETA Technologies, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

YETI Holdings, Inc.8-Kneutralmateriality 5/10

19-02-2026

YETI Holdings, Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on the affected position, type of change, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, performance comparisons, or directional indicators (positive, negative, or flat) are mentioned.

CVB FINANCIAL CORP8-Kneutralmateriality 4/10

19-02-2026

CVB Financial Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including affected positions, individuals involved, reasons for change, or any quantitative terms were provided in the filing summary. Sector is not specified.

INSMED Inc8-Kneutralmateriality 4/10

19-02-2026

Insmed Inc filed an 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with exhibits under Item 9.01. No specific details on the officer position affected, whether it was an appointment or resignation, reasons for the change, or any financial metrics from the results of operations are disclosed. No quantitative data, named executives, or scheduled events are mentioned.

Unknown8-Kneutralmateriality 3/10

19-02-2026

The company filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006118) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

Lucky Strike Entertainment Corp8-Kneutralmateriality 3/10

19-02-2026

Lucky Strike Entertainment Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative data such as compensation amounts are provided in the filing excerpt. Sector is not specified.

Paycom Software, Inc.8-Kneutralmateriality 6/10

19-02-2026

Paycom Software, Inc. filed an 8-K on 2026-02-19 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, appointment/resignation reasons, amendments, or disclosures are provided in the filing summary. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

OLD NATIONAL BANCORP /IN/8-Kneutralmateriality 4/10

19-02-2026

Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

BOK FINANCIAL CORP8-Kneutralmateriality 4/10

19-02-2026

BOK Financial Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed.

Unknown8-Kneutralmateriality 3/10

19-02-2026

The company filed an 8-K on February 19, 2026 (AccNo: 0001331463-26-000037), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual's name, appointment or resignation status, reasons for the change, or any quantitative data such as compensation amounts are provided in the filing excerpt. No positive or negative metrics, board outcomes, or scheduled events are mentioned.

Quarta-Rad, Inc.8-Kneutralmateriality 4/10

19-02-2026

Quarta-Rad, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial impacts are provided. No quantitative metrics, performance comparisons, or other material updates are mentioned.

WD 40 CO8-Kneutralmateriality 6/10

19-02-2026

WD-40 Company filed an 8-K on February 19, 2026 (AccNo: 0000105132-26-000016, Size: 397 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any quantitative financial impacts are provided in the filing summary. This appears to be an informational disclosure with no mentioned positive or negative performance metrics.

Texas Roadhouse, Inc.8-Kneutralmateriality 5/10

19-02-2026

Texas Roadhouse, Inc. filed an 8-K on 2026-02-19 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, and any financial metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or scheduled events are provided in the filing summary.

Sprouts Farmers Market, Inc.8-Kneutralmateriality 5/10

19-02-2026

Sprouts Farmers Market, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without additional context on implications.

APPLIED OPTOELECTRONICS, INC.8-Kneutralmateriality 6/10

19-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

DeFi Development Corp.8-Kneutralmateriality 3/10

19-02-2026

DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.

BALCHEM CORP8-Kneutralmateriality 5/10

19-02-2026

Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.

MATTHEWS INTERNATIONAL CORP8-Kneutralmateriality 5/10

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

SYNOPSYS INC8-Kneutralmateriality 4/10

19-02-2026

Synopsys Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. No quantitative metrics, performance comparisons, or other financial data mentioned.

EASTMAN KODAK CO8-Kneutralmateriality 4/10

19-02-2026

EASTMAN KODAK CO filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, appointment or resignation status, reasons for change, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

National Bank Holdings Corp8-Kneutralmateriality 3/10

19-02-2026

National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

Meritage Homes CORP8-Kneutralmateriality 5/10

19-02-2026

Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.

Viper Energy, Inc.8-Kneutralmateriality 3/10

19-02-2026

Viper Energy, Inc. filed an 8-K on 2026-02-19 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, whether it was an appointment or resignation, reasons for the change, timing, or any quantitative data are disclosed. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of details.

GoPro, Inc.8-Kneutralmateriality 5/10

19-02-2026

GoPro, Inc. filed an 8-K on 2026-02-19 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

  • Β·AccNo: 0001628280-26-009818
  • Β·Filing size: 221 KB
  • Β·Sector: NOT_DISCLOSED
Park Hotels & Resorts Inc.8-Kneutralmateriality 6/10

19-02-2026

Park Hotels & Resorts Inc. filed an 8-K on 2026-02-19 (AccNo: 0001617406-26-000003) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

  • Β·Filing size: 8 MB
Rein Therapeutics, Inc.8-Kneutralmateriality 5/10

19-02-2026

Rein Therapeutics, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059545), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, or compensatory terms are provided in the available information. Sector is not specified.

NNN REIT, INC.8-Kneutralmateriality 5/10

19-02-2026

NNN REIT, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059530, Size: 384 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer(s) involved, position affected, reason for change, or any quantitative metrics are NOT_DISCLOSED.

Columbus Circle Capital Corp II8-Kneutralmateriality 5/10

19-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative impacts were disclosed. No positive or negative metrics, performance comparisons, or governance implications were provided.

  • Β·Filing Accession Number: 0001213900-26-018446
  • Β·File Size: 469 KB
  • Β·Sector: not specified
Vanda Pharmaceuticals Inc.8-Kneutralmateriality 5/10

19-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.

Hanover Bancorp, Inc. /MD8-Kneutralmateriality 4/10

19-02-2026

Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.

ManpowerGroup Inc.8-Kneutralmateriality 3/10

19-02-2026

ManpowerGroup Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

  • Β·Filing accession number: 0001193125-26-059576
  • Β·Filing size: 607 KB
  • Β·Sector: NOT_DISCLOSED
urban-gro, Inc.8-Kneutralmateriality 4/10

19-02-2026

urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

EXPEDITORS INTERNATIONAL OF WASHINGTON INC8-Kneutralmateriality 4/10

19-02-2026

Expeditors International of Washington Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or financial metrics are disclosed.

Artiva Biotherapeutics, Inc.8-Kneutralmateriality 4/10

19-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, timing, or any quantitative financial metrics are provided in the available information. No positive or negative performance metrics, comparisons, or impacts are mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 34 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Board Director Changes SEC Filings β€” February 18, 2026 | Gunpowder Blog